What is the recommended dose of Cipro (ciprofloxacin) for an adult patient without significant underlying health conditions presenting with a nail wound through a shoe into the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ciprofloxacin Dosing for Nail Puncture Wound Through Shoe

For an adult with a nail puncture wound through a shoe into the foot, administer ciprofloxacin 750 mg orally twice daily for 7-14 days after surgical debridement, with treatment duration depending on presence of osteochondritis. 1

Initial Management Requirements

Surgical intervention must precede antibiotic therapy and should include debridement, drainage of any purulent material, and exploration of underlying bone structures. 1 This is critical because the rubber sole material from shoes can be driven deep into the wound, creating a foreign body reservoir for infection—particularly with Pseudomonas aeruginosa, which thrives in the moist environment between rubber and skin. 2

Key Clinical Decision Points

  • Cellulitis only: Ciprofloxacin 750 mg orally twice daily for 7 days after surgical debridement 1
  • Osteochondritis present: Ciprofloxacin 750 mg orally twice daily for 14 days after surgical debridement 1
  • Initial IV therapy option: If patient requires hospitalization, may start with ciprofloxacin 400 mg IV every 12 hours for 24 hours, then transition to oral 750 mg twice daily 1

Rationale for This Specific Regimen

The 750 mg twice daily dosing is specifically validated for nail puncture wounds through shoes, where Pseudomonas aeruginosa is the predominant pathogen (isolated in 78% of cases in the definitive study). 1 This organism has particular affinity for the rubber-foam interface of shoe soles and requires aggressive dosing for bone penetration when osteochondritis develops. 1

Standard lower respiratory or skin infection dosing (500 mg twice daily) is inadequate for this indication. 3 The higher dose ensures adequate bone penetration and pseudomonal coverage. 1

Critical Timing Considerations

Delayed presentation significantly worsens outcomes. Patients who present more than 5 days after injury are more likely to require surgical intervention, and those presenting after 10 days have substantially higher treatment failure rates. 2 The median time to admission for treatment failures was 10 days versus 2 days for successful outcomes. 2

Common Pitfall to Avoid

Do not prescribe antibiotics before surgical debridement in the community setting. Patients who received antibiotics before hospitalization had higher treatment failure rates (100% of failures had received prior antibiotics versus 47.2% of successes). 2 This likely reflects inadequate source control and selection of resistant organisms.

Microbiological Coverage

This regimen provides excellent coverage for:

  • Pseudomonas aeruginosa (primary pathogen in nail-through-shoe injuries) 1
  • Staphylococcus aureus (including methicillin-resistant strains) 4, 5
  • Gram-negative enteric organisms 4

All isolates in the landmark study were susceptible to ciprofloxacin, with 100% cure rate when combined with surgical intervention. 1

Monitoring and Adjunctive Care

  • Tetanus prophylaxis: Administer Tdap if not vaccinated within 10 years 6
  • Imaging: Obtain plain radiographs initially; if osteochondritis suspected clinically but radiographs negative, obtain technetium-99m bone scan 1
  • Ultrasonography: Consider for detecting retained foreign body (rubber fragments from shoe sole) 2
  • Renal function: No dosage adjustment needed unless creatinine clearance <30 mL/min 3, 4

Special Populations Requiring Modified Approach

High-risk patients warrant broader empirical coverage initially:

  • Immunocompromised patients 6
  • Diabetic patients (40% of treatment failures were diabetic versus 9.9% of successes) 2
  • Patients with advanced liver disease 6
  • Asplenic patients 6

For these patients, consider adding vancomycin or linezolid to cover resistant gram-positive organisms until culture results available, as the IDSA guidelines recommend broader coverage for severe infections in compromised hosts. 6

Administration Specifics

  • Take at least 2 hours before or 6 hours after antacids, calcium, iron, or zinc supplements 3
  • Can be taken with or without food 3
  • Maintain adequate hydration 3

Expected Outcomes

With appropriate surgical debridement followed by ciprofloxacin 750 mg twice daily, expect 100% cure rate for uncomplicated cases and no reinfection when treatment duration is adequate. 1 Treatment success does not correlate with fever, white blood cell count, or erythrocyte sedimentation rate—clinical improvement and wound healing are the primary endpoints. 2

References

Research

Oral ciprofloxacin for treatment of infection following nail puncture wounds of the foot.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Nail puncture wound through a rubber-soled shoe: a retrospective study of 96 adult patients.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.